Human Adenovirus Type 26 Induced IL-6 Gene Expression in an αvβ3 Integrin- and NF-κB-Dependent Manner

The low seroprevalent human adenovirus type 26 (HAdV26)-based vaccine vector was the first adenovirus-based vector to receive marketing authorization from European Commission. HAdV26-based vaccine vectors induce durable humoral and cellular immune responses and, as such, represent a highly valuable...

Descripción completa

Detalles Bibliográficos
Autores principales: Nestić, Davor, Božinović, Ksenija, Drašković, Isabela, Kovačević, Alen, van den Bosch, Jolien, Knežević, Jelena, Custers, Jerome, Ambriović-Ristov, Andreja, Majhen, Dragomira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028149/
https://www.ncbi.nlm.nih.gov/pubmed/35458402
http://dx.doi.org/10.3390/v14040672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028149/
https://www.ncbi.nlm.nih.gov/pubmed/35458402
http://dx.doi.org/10.3390/v14040672

Ejemplares similares